Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 762

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 762
---
Us.

| Balance - June 30, 2024           |     | Number ofRSU(in thousands) | 2  |   |
|:----------------------------------|:----|:---------------------------|:---|:--|
| Vesting of restricted stock units |     |                            | (2 | ) |
| Balance - September 30, 2024      |     |                            | —  |   |

Common stock warrants

The following table sets forth changes in outstanding common stock warrants:

|                                        |     | Number ofWarrants(in thousands) |    |   |     | Weightedaverageexerciseprice$ |          |
| Balance - June 30, 2024                |     |                                 | 19 |   |     |                               | 1,399.72 |
| Expiry of warrants issued for services |     |                                 | (2 | ) |     |                               | 1,750.00 |
| Balance - September 30, 2024           |     |                                 | 17 |   |     |                               | 1,362.41 |

The following table summarizes the Company’s outstanding common stock warrants as of September 30, 2024:

| Description of warrants      
 2022 April Investor warrants 
 2022 Investor warrants       |     | Number(in thousands) |  9 
  7 |     | Exerciseprice $ |   717.50 
 2,187.50 |     | Expiry date | April 14, 2027   
 March 28, 2025   |
|:-----------------------------|:----|:---------------------|---:|:----|:----------------|---------:|:----|:------------|:-----------------|
| 2022 April Agent warrants    |     |                      |  1 |     |                 | 1,159.20 |     |             | October 14, 2026 |
|                              |     |                      | 17 |     |                 |          |     |             |                  |

<div align='center'>F-43</div>

Series C Preferred Stock warrants

In connection with the Series C Preferred Stock private placement, the Company issued 2,504Series C Agent Warrants. The Series C Agent Warrants had an exercise price of $ 1,000per share, provide for a cashless exercise feature, and wee exercisable for a period of four years from August 19, 2020. The Series C Agent Warrants expired unex